9:22 AM
Leo Group India
| ||
| CFO Moves: Aoxing Pharmaceutical, Adanac Molybdenum, KaloBios ... Wall Street Journal (blog) Aoxing Pharmaceutical's chief financial officer has resigned; Adanac Molybdenum promoted its vice president of administration to CFO, KaloBios Pharmaceuticals hired its first CFO. See all stories on this topic » | ||
| Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option Sacramento Bee PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ & Zertane™), licensing distribution of these drugs and developing additional new drugs, today ... See all stories on this topic » | ||
| Aurobindo to challenge AP unit ban Daily News & Analysis "The units of Aurobindo are the best managed and are engaged in manufacture of active pharmaceutical ingredients (APIs). Most of the APIs produced in these units are meant for captive consumption in the company's formulations units. The company is ... See all stories on this topic » | ||
| Pharmaceuticals: Being Lean While The Markets Are Mean Seeking Alpha Pharmaceuticals have traditionally been a safe haven during bearish markets. The Conference Board Consumer Confidence Index has been easing for the past four months and now sits 10% below its February peak. GDP growth is slowing, the presidential ... See all stories on this topic » | ||
| Data firm forecast: Global spending on medications will slow in next four years LubbockOnline.com That would put total pharmaceutical spending at about $1 trillion in 2016. Spending will grow at "historically low levels" in the U.S. and might even decline by a percent in Europe, the report states. "We're going to see the cost of medicines drop ... See all stories on this topic » | ||
| ||
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva to Report Second ... 4-traders Teva Pharmaceutical Industries Ltd. announced today that it will release its second quarter 2012 financial results on Thursday, August 2, 2012 at 7:00 a.m. EDT. ... | July 13, 2012. See all stories on this topic » | ||
| Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial ... PharmaLive.com (press release) NASHVILLE, Tenn., July 12, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release its second quarter 2012 results after the market closes on Thursday, August 2, 2012. A conference call and live Internet ... See all stories on this topic » | ||
| Mark-to-market loss may hurt profit growth Business Standard First quarter results of the pharmaceutical sector are expected to be a mixed bag. A weak rupee will shore up earnings at the operating level, while profit growth is likely to get affected due to foreign exchange (forex) losses. Sales growth will have ... See all stories on this topic » | ||
| Watson's Generic ARTHROTEC(R) Receives FDA Approval Melodika.net (press release) The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment